Data collection and evaluation in the regional COVID-19 NPL register to record the effects of a SARS-CoV-2 infection on patients with cancer disease

Data collection and evaluation in the regional COVID-19 NPL register to record the effects of a SARS-CoV-2 infection on patients with cancer disease - COVICA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031094

Enrollment

Registered

2023-02-09

Start date

2021-12-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C Codes, U07.1 (Cancer and Covid-19)

Interventions

Group 1: Cancer patients with COVID infection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who are currently suffering from cancer and are = 18 years old Have a proven SARS-CoV-2 infection or All patients = 18 years of age who have had cancer in the past 5 years and have a proven SARS-CoV-2 infection

Exclusion criteria

Exclusion criteria: All patients in recurrence-free follow-up > 5 years after ED of a malignancy, ICD-10 C.44 (e.g. basal cell Ca), D-codes, (in situ tumors) All patients < 18 years

Design outcomes

Primary

Measure	Time frame
Change in cancer therapy (therapy interruptions and delays)	—

Secondary

Measure	Time frame
Course of the COVID disease	—

Countries

Germany

Contacts

Public ContactNikolas Christian Cornelius von Bubnoff

Direktor, Geschäftsführender Vorstand Universitäres Cancer Center S-H (UCCSH), UNIVERSITÄTSKLINIKUM Schleswig-Holstein

NikolasChristianCornelius.vonBubnoff@uksh.de+49 451 500-44151

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026